TheraCryf PLC
LSE:TCF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TheraCryf PLC
LSE:TCF
|
UK |
|
Indofood Agri Resources Ltd
F:ZVF
|
SG |
|
I2S SA
PAR:ALI2S
|
FR |
|
T
|
Trikomsel Oke Tbk PT
IDX:TRIO
|
ID |
|
H
|
Harmonychain AS
F:7EW
|
NO |
|
I
|
INX Ltd
OTC:INXTF
|
GI |
|
Minco Capital Corp
OTC:MGHCF
|
CA |
|
S
|
Sinomach Automobile Co Ltd
SSE:600335
|
CN |
|
B
|
Baird Medical Investment Holdings Ltd
NASDAQ:BDMD
|
HK |
|
M
|
Memsensing Microsystems Suzhou China Co Ltd
SSE:688286
|
CN |
|
Ezconn Corp
TWSE:6442
|
TW |
|
Shanghai Fosun Pharmaceutical Group Co Ltd
HKEX:2196
|
CN |
|
Tridomain Performance Materials Tbk PT
IDX:TDPM
|
ID |
|
Inmobiliaria del Sur SA
LSE:0HFP
|
ES |
|
Triple P NV
OTC:TPPPF
|
NL |
|
D
|
Da Hui Ltd
TPEX:5276
|
TW |
|
Odfjell SE
OSE:ODFB
|
NO |
|
A
|
Art Group Holdings Ltd
HKEX:565
|
HK |
|
Trust Finance Indonesia Tbk PT
IDX:TRUS
|
ID |
|
Cegedim SA
PAR:CGM
|
FR |
Bankruptcy Probability
TheraCryf PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
TheraCryf PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
T
|
TheraCryf PLC
LSE:TCF
|
4m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
462.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
141.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
88.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
57.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
60.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
TheraCryf PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, TheraCryf PLC has no debt.
You can find a full breakdown on its Balance Sheet.